Bank CEOs meet with Trump to discuss Fannie Mae and Freddie Mac - Bloomberg
WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE:TMO) announced Thursday that its Board of Directors has authorized a quarterly cash dividend of $0.43 per common share. The dividend will be payable on October 15, 2025, to shareholders of record as of September 15, 2025. According to InvestingPro data, TMO has maintained dividend payments for 14 consecutive years and has raised its dividend for 7 straight years, with a current yield of 0.41%.
Thermo Fisher Scientific, which describes itself as a leader in serving science, reported annual revenue of $42.9 billion in the last twelve months. With a market capitalization of $162.6 billion and an "GOOD" Financial Health score from InvestingPro, the company maintains a strong position in the Life Sciences Tools & Services industry. The company provides laboratory equipment, analytical instruments, pharmaceutical services, and other scientific products through its brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Analysts maintain a bullish outlook on the stock, with additional insights available in InvestingPro’s comprehensive research report.
The dividend announcement was made in a press release issued by the company. The stock currently trades at a P/E ratio of 25.2, with analysts expecting profitability to continue in the current fiscal year.
In other recent news, Thermo Fisher Scientific reported its first-quarter earnings for 2025, surpassing analysts’ expectations with an adjusted earnings per share (EPS) of $5.15, compared to the forecasted $5.11. The company’s revenue for the quarter reached $10.36 billion, slightly above the anticipated $10.23 billion. Additionally, Thermo Fisher has announced a definitive agreement to acquire Solventum’s purification and filtration business for $4.1 billion. This acquisition is expected to enhance the company’s capabilities in the bioprocessing market. In a strategic move, Thermo Fisher plans to invest $2 billion in its U.S. operations over the next four years, focusing on enhancing manufacturing operations and research and development. The company has also declared a quarterly cash dividend of $0.43 per common share, reflecting its commitment to delivering value to shareholders. On the analyst front, Scotiabank adjusted Thermo Fisher’s price target to $605 from $650, maintaining a Sector Perform rating, citing macroeconomic challenges despite strong quarterly performance. Additionally, Thermo Fisher has granted performance-based restricted stock units to its CEO, Marc N. Casper, valued at approximately $60 million, as an incentive for long-term shareholder return outperformance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.